Lantheus Holdings Files Q2 2024 10-Q

Ticker: LNTH · Form: 10-Q · Filed: Jul 31, 2024 · CIK: 1521036

Lantheus Holdings, Inc. 10-Q Filing Summary
FieldDetail
CompanyLantheus Holdings, Inc. (LNTH)
Form Type10-Q
Filed DateJul 31, 2024
Risk Levelmedium
Pages16
Reading Time19 min
Key Dollar Amounts$0.01
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financials, healthcare

TL;DR

Lantheus Holdings filed its Q2 2024 10-Q, detailing financial performance and operational updates.

AI Summary

Lantheus Holdings, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported financial results and operational updates. Key financial figures and business segments were detailed, reflecting the company's performance in the second quarter of 2024.

Why It Matters

This filing provides investors with a detailed look at Lantheus Holdings' financial health and operational performance for the second quarter of 2024, crucial for investment decisions.

Risk Assessment

Risk Level: medium — The filing contains standard financial disclosures for a public company, but the inherent risks of the healthcare and diagnostics industry warrant a medium risk level.

Key Numbers

  • 15.33 — Fiscal Year End (Indicates the company's fiscal year concludes on December 31st.)

Key Players & Entities

  • Lantheus Holdings, Inc. (company) — Filer of the 10-Q
  • 20240630 (date) — End of the reporting period
  • 20240731 (date) — Filing date
  • 0001521036 (company) — Central Index Key for Lantheus Holdings, Inc.

FAQ

What is the reporting period for this 10-Q filing?

The reporting period for this 10-Q filing is the quarter ended June 30, 2024.

When was this 10-Q filed with the SEC?

This 10-Q was filed on July 31, 2024.

What is the Central Index Key (CIK) for Lantheus Holdings, Inc.?

The Central Index Key for Lantheus Holdings, Inc. is 0001521036.

What is the Standard Industrial Classification (SIC) code for Lantheus Holdings, Inc.?

The Standard Industrial Classification code for Lantheus Holdings, Inc. is 2835, which corresponds to 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES'.

What was the former name of Lantheus Holdings, Inc.?

The former name of Lantheus Holdings, Inc. was Lantheus MI Holdings, Inc., with a date of name change on May 17, 2011.

Filing Stats: 4,667 words · 19 min read · ~16 pages · Grade level 17.2 · Accepted 2024-07-31 07:50:41

Key Financial Figures

  • $0.01 — ich registered Common stock, par value $0.01 per share LNTH The Nasdaq Global Market

Filing Documents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION 1

Financial Statements (Unaudited)

Item 1. Financial Statements (Unaudited) 1 Condensed Consolidated Balance Sheets 1 Condensed Consolidated Statements of Operations 2 Condensed Consolidated Statements of Comprehensive Income 3 Condensed Consolidated Statements of Changes in Stockholders' Equity 4 Condensed Consolidated Statements of Cash Flows 5 Notes to Condensed Consolidated Financial Statements 7

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 22

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 35

Controls and Procedures

Item 4. Controls and Procedures 36

OTHER INFORMATION

PART II. OTHER INFORMATION 37

Legal Proceedings

Item 1. Legal Proceedings 37

Risk Factors

Item 1A. Risk Factors 38

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 45

Defaults Upon Senior Securities

Item 3. Defaults Upon Senior Securities 45

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 45

Other Information

Item 5. Other Information 45

Exhibits

Item 6. Exhibits 46

SIGNATURES

SIGNATURES 47 Table of Contents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements (Unaudited)

Item 1. Financial Statements (Unaudited) Lantheus Holdings, Inc. Condensed Consolidated Balance Sheets (Unaudited) (in thousands, except par value) June 30, 2024 December 31, 2023 Assets Current assets Cash and cash equivalents $ 757,018 $ 713,656 Accounts receivable, net 372,288 284,292 Inventory 70,516 64,029 Other current assets 24,165 16,683 Assets held for sale 7,159 7,159 Total current assets 1,231,146 1,085,819 Investment in equity securities 116,423 — Property, plant and equipment, net 158,158 146,697 Intangibles, net 172,239 151,985 Goodwill 61,189 61,189 Deferred tax assets, net 151,185 150,198 Other long-term assets 49,491 55,261 Total assets $ 1,939,831 $ 1,651,149 Liabilities and stockholders' equity Current liabilities Current portion of long-term debt and other borrowings $ 868 $ 823 Accounts payable 49,774 41,189 Accrued expenses and other liabilities 212,643 145,338 Total current liabilities 263,285 187,350 Asset retirement obligations 23,130 22,916 Long-term debt, net and other borrowings 563,188 561,670 Other long-term liabilities 63,543 63,321 Total liabilities 913,146 835,257 Commitments and contingencies (See Note 18) Stockholders' equity Preferred stock ($ 0.01 par value, 25,000 shares authorized; no shares issued and outstanding) — — Common stock ($ 0.01 par value, 250,000 shares authorized; 70,750 and 69,863 shares issued as of June 30, 2024 and December 31, 2023, respectively) 708 699 Additional paid-in capital 775,545 757,727 Treasury Stock at cost - 1,339 shares as of June 30, 2024 and December 31, 2023 ( 75,000 ) ( 75,000 ) Retained earnings 326,642 133,503 Accumulated other comprehensive loss ( 1,210 ) ( 1,037 ) Total stockholders' equity 1,026,685 815,892 Total liabilities and stockholders' equity $ 1,939,831 $ 1,651,149 The accompanying notes are an integral part of these condensed consolidated financial statements. 1 Table of Contents Lantheus Holdings, Inc. Condensed Consolida

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.